Cargando…

The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia

OBJECTIVE: To explore disease severity and risk factors for 30-day mortality of adult immunocompromised (IC) patients hospitalized with influenza-related pneumonia (Flu-p). METHOD: A total of 122 IC and 1191 immunocompetent patients hospitalized with Flu-p from January 2012 to December 2018 were rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liang, Han, Xiudi, Li, YanLi, Zhang, Chunxiao, Xing, Xiqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383249/ https://www.ncbi.nlm.nih.gov/pubmed/34429126 http://dx.doi.org/10.1186/s12941-021-00462-7

Ejemplares similares

Complications of Cardiovascular Events in Patients Hospitalized with Influenza-Related Pneumonia
por: Chen, Liang, et al.
Publicado: (2021)

The Clinical Characteristics and Outcomes of Adult Patients With Pneumonia Related to Three Paramyxoviruses
por: Chen, Liang, et al.
Publicado: (2021)

Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019
por: Chen, Liang, et al.
Publicado: (2021)

Flu-IV score: a predictive tool for assessing the risk of invasive mechanical ventilation in patients with influenza-related pneumonia
por: Chen, Liang, et al.
Publicado: (2022)

Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: a multicenter retrospective study
por: Chen, Liang, et al.
Publicado: (2020)

FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients
por: Chen, Liang, et al.
Publicado: (2020)

Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score)
por: Chen, Liang, et al.
Publicado: (2020)

The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study
por: Chen, Liang, et al.
Publicado: (2020)

Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network
por: Han, Xiudi, et al.
Publicado: (2022)

Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia
por: Han, Xiudi, et al.
Publicado: (2018)

Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
por: Chen, Liang, et al.
Publicado: (2018)

Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
por: Han, Xiudi, et al.
Publicado: (2021)

Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013–2019
por: Chen, Liang, et al.
Publicado: (2020)

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients
por: Han, Xiudi, et al.
Publicado: (2020)

Comparison of the Clinical Characteristics and Severity of Influenza and Non-influenza Respiratory Virus-Related Pneumonia in China: A Multicenter, Real-World Study
por: Chen, Liang, et al.
Publicado: (2020)

Development and Validation of Nomogram for Hospital Mortality in Immunocompromised Patients with Severe Pneumonia in Intensive Care Units: A Single-Center, Retrospective Cohort Study
por: Yang, Lei, et al.
Publicado: (2022)

Clinical features and outcome of influenza pneumonia in critically-ill immunocompromised patients
por: Raymond, Matthieu, et al.
Publicado: (2022)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study
por: Ramirez, Julio, et al.
Publicado: (2021)

Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease
por: Ortiz, Justin R., et al.
Publicado: (2014)

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Clinical Features and Outcomes of Immunocompromised Adults Hospitalized with Laboratory-confirmed Influenza in the USA, 2011–2015
por: Collins, Jennifer, et al.
Publicado: (2017)

Severe Nocardia pneumonia in an immunocompromised patient with alpha‐1 antitrypsin deficiency
por: Chan, Daryl E. C. Y., et al.
Publicado: (2020)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts
por: Memoli, Matthew J., et al.
Publicado: (2014)

Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study
por: Johnson, Christopher S, et al.
Publicado: (2014)

94. Pneumonia Severity Scores Poorly Predict Severe Outcomes Among Adults Hospitalized with Influenza
por: Doyle, Joshua, et al.
Publicado: (2019)

Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China
por: Zhang, Yulin, et al.
Publicado: (2020)

Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality
por: Ishiguro, Takashi, et al.
Publicado: (2017)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia
por: Kim, Se Jin, et al.
Publicado: (2015)

Metagenomic Next-Generation Sequencing for Pathogenic Diagnosis and Antibiotic Management of Severe Community-Acquired Pneumonia in Immunocompromised Adults
por: Sun, Ting, et al.
Publicado: (2021)

Evaluation of Pneumonia Severity and Acute Physiology Scores to Predict ICU Admission and Mortality in Patients Hospitalized for Influenza
por: Muller, Matthew P., et al.
Publicado: (2010)

Clinical application of metagenomic next-generation sequencing in non-immunocompromised patients with severe pneumonia supported by veno-venous extracorporeal membrane oxygenation
por: Li, Xing-Xing, et al.
Publicado: (2023)

Predictive Value of Annenxin A1 for Disease Severity and Prognosis in Patients with Community-Acquired Pneumonia
por: Gu, Minghao, et al.
Publicado: (2023)

Environmental Cadmium and Mortality from Influenza and Pneumonia in U.S. Adults
por: Park, Sung Kyun, et al.
Publicado: (2020)

Next-generation sequencing of the BALF in the diagnosis of community-acquired pneumonia in immunocompromised patients
por: Pan, Tingting, et al.
Publicado: (2019)

Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Urea-to-Albumin Ratio and In-Hospital Mortality in Severe Pneumonia Patients
por: Tian, Yu, et al.
Publicado: (2021)

Case Report: Presumed Respiratory Syncytial Virus Pneumonia in Three Immunocompromised Adults
por: Kasupski, George J., et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_q1012mugtg55jkiam24b80snhn